Showing 2021-2030 of 2314 results for "".
- FDA Review Confirms Efficacy of Moderna’s mRNA-1273 Vaccine Against COVID-19https://modernod.com/news/fda-review-confirms-efficacy-of-modernas-mrna-1273-vaccine-against-covid-19/2478666/According to briefing documents released ahead of an FDA advisory panel meeting on December 17, agency staff concluded that the efficacy of Moderna’s candidate COVID-19 vaccine mRNA-1273 at preventing coronavirus infections 14 days after a second dose was consistent, at 94.1%, with results
- Palatin Technologies Announces Positive Results From its Phase 2 Study of PL9643 in Patients With Dry Eye Diseasehttps://modernod.com/news/palatin-technologies-announces-positive-results-from-its-phase-2-study-of-pl9643-in-patients-with-dry-eye-disease/2478661/Palatin Technologies announced positive results in its phase 2 study of PL9643 for the treatment of dry eye disease (DED). Statistically significant improvement in multiple signs and symptoms was achieved in the moderate to severe patient population after 2 weeks of dosing and at the 12-week visi
- Nicox Initiates Phase 2b Trial of NCX 4251, a Potential First-in-Class Treatment for Blepharitishttps://modernod.com/news/nicox-initiates-phase-2b-trial-of-ncx-4251-a-potential-first-in-class-treatment-for-blepharitis/2478662/Nicox SA announced the initiation of the Mississippi trial, a phase 2b clinical trial of NCX 4251, evaluating once-daily dosed NCX 4251 0.1% versus placebo in patients with acute exacerbations of blepharitis. NCX 4251 is a novel patented ophthalmic suspension of fluticasone propionate nanocrystal
- Bruder Introduces Pre-Surgical Patient Prep Kithttps://modernod.com/news/bruder-introduces-pre-surgical-patient-prep-kit/2478655/Bruder has introduced the Bruder Sx Pre-Surgical Patient Prep Kit, which allow patients’ hygiene products to be available in a single, self-contained kit. Doctors can provide the kit directly in their practices
- FDA Panel Endorses Pfizer, BioNTech’s COVID-19 Vaccinehttps://modernod.com/news/fda-panel-endorses-pfizer-biontechs-covid-19-vaccine/2478650/An FDA advisory panel that convened Thursday to discuss Pfizer and BioNTech’s COVID-19 vaccine BNT162b2 voted 17-4, with one abstention, in favor of authorizing it for emergency use in people 16 years and older. The vote follows the release of briefing documents earlier this week in which F
- No Red Flags in FDA Review of Pfizer, BioNTech’s COVID-19 Vaccine Candidatehttps://modernod.com/news/no-red-flags-in-fda-review-of-pfizer-biontechs-covid-19-vaccine-candidate/2478641/In briefing documents released Tuesday ahead of an FDA advisory committee meeting on December 10, agency staff said that efficacy data submitted by Pfizer and BioNTech in support of BNT162b2 are “consistent” with recommendations previously detailed in guidance on the emergency-use aut
- Aldeyra Announces First Patient Enrolled in the Phase 3 TRANQUILITY Trial of Reproxalap for the Treatment of Dry Eye Diseasehttps://modernod.com/news/aldeyra-announces-first-patient-enrolled-in-the-phase-3-tranquility-trial-of-reproxalap-for-the-treatment-of-dry-eye-disease/2478638/Aldeyra Therapeutics announced enrollment of the first patient in the phase 3 TRANQUILITY trial of 0.25% reproxalap ophthalmic solution for the treatment of dry eye disease. The multicenter randomized, double-masked, parallel design, vehicle-controlled clinical trial will assess the effica
- Supply Chain Snags Blamed For Cut to Pfizer COVID-19 Vaccine Rollout This Year: Reporthttps://modernod.com/news/supply-chain-snags-blamed-for-cut-to-pfizer-covid-19-vaccine-rollout-this-year-report/2478626/Pfizer and BioNTech expect to ship only half of the 100 million doses of COVID-19 vaccine they had originally targeted for worldwide delivery this year because of hurdles encountered with the supply chain, according to a report in The Wall Street Journal on Thursday. A person directly in
- CDC Panel Recommends Healthcare Workers, Long-Term Care Residents and Staff Be First to Get COVID-19 Vaccinehttps://modernod.com/news/cdc-panel-recommends-healthcare-workers-long-term-care-residents-and-staff-be-first-to-get-covid-19-vaccine/2478613/A key federal panel has recommended healthcare workers as well as residents and staff in long-term care facilities get the first doses of COVID-19 vaccines, according to a FierceHealthcare
- Alcon Joins Health Care Alliance for Patient Safetyhttps://modernod.com/news/alcon-joins-health-care-alliance-for-patient-safety/2478602/The Health Care Alliance for Patient Safety (APS) announced Alcon as its newest member. “APS partners and patient safety advocates are excited to have Alcon join our effort to advance patient safety and strengthen the doctor-patient relationship, which is the foundation of personalized hea